Celebrex - Celecoxib capsules - Pfizer - COX-2 inhibitor approved for ankylosing spondylitis

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2005年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [41] Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib
    Greene, AK
    Alwayn, IPJ
    Nose, V
    Flynn, E
    Sampson, D
    Zurakowski, D
    Folkman, J
    Puder, M
    ANNALS OF SURGERY, 2005, 242 (01) : 140 - 146
  • [42] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Claudia Bocca
    Francesca Bozzo
    Andrea Bassignana
    Antonella Miglietta
    Molecular and Cellular Biochemistry, 2011, 350 : 59 - 70
  • [43] Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo
    Xiao, Yitao
    Teng, Yincheng
    Zhang, Rui
    Luo, Laimin
    ONCOLOGY LETTERS, 2012, 4 (06) : 1219 - 1224
  • [44] Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat
    Tibble, JA
    Sigthorsson, G
    Foster, R
    Bjarnason, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (08) : 802 - 807
  • [45] Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis
    Abou-Issa, HM
    Alshafie, GA
    Seibert, K
    Koki, AT
    Masferrer, JL
    Harris, RE
    ANTICANCER RESEARCH, 2001, 21 (05) : 3425 - 3432
  • [46] Celecoxib (a selective COX-2 inhibitor). Is the gastrointestinal toxicity of NSAIDs on its way out?
    Chaussade, S
    SEMAINE DES HOPITAUX, 1999, 75 (17-18): : 516 - 521
  • [47] Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.
    Geis, GS
    Stead, H
    Morant, S
    Naudin, R
    Hubbard, R
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S316 - S316
  • [48] Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo
    Bensen, WG
    Zhao, SZ
    Burke, TA
    Zabinski, RA
    Makuch, RW
    Maurath, CJ
    Agrawal, NM
    Geis, GS
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (08) : 1876 - 1883
  • [49] Celecoxib: A specific cyclooxygenase-2 (COX-2) inhibitor with antiangiogenic and anticancer activities.
    Masferrer, JL
    Leahy, K
    Zweifel, BS
    Moore, R
    Heuvelman, D
    Seibert, K
    Koki, AT
    CLINICAL CANCER RESEARCH, 2000, 6 : 4486S - 4486S
  • [50] A phase I-II study of COX-2 inhibitor, Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128
    Gaffney, DK
    Winter, K
    Dicker, A
    Miller, B
    Jhingran, A
    Ryu, J
    Avizonis, V
    Fromm, M
    Greven, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S93 - S94
12345